Form 8.3 - AON PLC

Form 8.3 - AON PLC

BARCLAYS PLC

 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in AON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 12 February 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)

(1)

Relevant securities

427,010

0.19%

2,188,144

0.96%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

474,034

0.21%

30,257

0.01%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

23,000

0.01%

23,000

0.01%

 

 

 

 

TOTAL:

 

 

 

 

924,044

0.40%

2,241,401

0.98%

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit

Purchase

2

227.9525 USD

Purchase

3

230.1900 USD

Purchase

7

228.8142 USD

Purchase

57

229.2850 USD

Purchase

70

228.1600 USD

Purchase

99

228.0740 USD

Purchase

100

229.8700 USD

Purchase

100

227.6800 USD

Purchase

100

228.1400 USD

Purchase

150

228.2071 USD

Purchase

200

226.9950 USD

Purchase

200

228.1900 USD

Purchase

218

228.9294 USD

Purchase

300

226.7433 USD

Purchase

372

228.8500 USD

Purchase

800

227.4075 USD

Purchase

915

227.4610 USD

Purchase

953

228.1308 USD

Purchase

1,074

227.3088 USD

Purchase

1,134

226.9897 USD

Purchase

1,363

228.0922 USD

Purchase

1,702

228.6839 USD

Purchase

1,900

228.6207 USD

Purchase

1,901

228.3517 USD

Purchase

1,978

228.0400 USD

Purchase

2,000

228.2190 USD

Purchase

2,000

228.2845 USD

Purchase

2,041

228.7257 USD

Purchase

2,529

228.4339 USD

Purchase

2,900

228.6781 USD

Purchase

3,400

228.2300 USD

Purchase

3,435

227.8674 USD

Purchase

4,095

227.9035 USD

Purchase

4,388

228.0719 USD

Purchase

5,321

227.5331 USD

Purchase

5,813

228.2454 USD

Purchase

9,179

227.9620 USD

Purchase

12,595

228.6111 USD

Purchase

40,872

228.1956 USD

Sale

3

230.1900 USD

Sale

5

228.1300 USD

Sale

5

228.1400 USD

Sale

7

228.8142 USD

Sale

23

228.1200 USD

Sale

38

229.2850 USD

Sale

40

228.2100 USD

Sale

53

228.8500 USD

Sale

66

228.0740 USD

Sale

70

228.1600 USD

Sale

100

228.0650 USD

Sale

100

228.0000 USD

Sale

100

228.9900 USD

Sale

100

229.1400 USD

Sale

100

228.1500 USD

Sale

100

229.8700 USD

Sale

100

228.0900 USD

Sale

117

228.7296 USD

Sale

123

228.5700 USD

Sale

210

228.0533 USD

Sale

320

228.8512 USD

Sale

346

228.1644 USD

Sale

400

228.0662 USD

Sale

400

228.0675 USD

Sale

500

228.0560 USD

Sale

500

228.0700 USD

Sale

506

228.0527 USD

Sale

535

228.1031 USD

Sale

852

228.1095 USD

Sale

903

228.2482 USD

Sale

920

228.0659 USD

Sale

943

227.5753 USD

Sale

1,012

227.4219 USD

Sale

1,674

227.1921 USD

Sale

1,974

227.9410 USD

Sale

2,196

228.3349 USD

Sale

2,559

228.0400 USD

Sale

2,612

227.9684 USD

Sale

3,376

228.0753 USD

Sale

7,870

228.9104 USD

Sale

16,889

227.7078 USD

Sale

67,374

228.2738 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure:

15 Feb 2021

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates

Call Options

Purchased

23,000

220.0000

American

Jul 16, 2021

Put Options

Purchased

-23,000

200.0000

American

Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

UK 100

Latest directors dealings